土壤易氧化有机碳与溶解性有机碳对荒漠草地沙漠化过程中土壤碳库变异的表征

以干旱、半干旱地区荒漠草地不同沙漠化阶段土壤为研究对象,研究不同沙漠化阶段土壤易氧化有机碳与溶解性有机碳含量和分配比例变异规律,分析不同沙漠化阶段土壤碳库指数变化,探讨荒漠草地沙漠化过程中土壤易氧化有机碳与溶解性有机碳对土壤碳库的表征作用。结果表明,随着荒漠草地沙漠化程度的加剧,易氧化有机碳含量表现出一定的波动性,但整体呈下降趋势,溶解性有机碳含量呈线性下降。易氧化有机碳和溶解性有机碳分配比例均在荒漠草地达到最大值,在半固定沙地达到最小值。利用易氧化有机碳含量计算的土壤碳库管理指数随荒漠草地沙漠化程度增加表现出先下降后上升趋势,利用溶解性有机碳含量计算的土壤碳库管理指数呈线性下降趋势。易氧化有机碳、溶解性有机碳含量与土壤有机碳均显著正相关,但溶解性有机碳的相关系数略高于易氧化有机碳。通过比较活度敏感指数和碳库管理指数敏感指数发现,荒漠草地逆向演替至固定沙地过程中,易氧化有机碳的各项敏感指数均高于溶解性有机碳。固定沙地演替至流动沙地过程中,溶解性有机碳的各项敏感指数均高于易氧化有机碳,表明易氧化有机碳能够较好地表征荒漠草地沙漠化前期土壤碳库变化,而荒漠草地沙漠化中期和后期利用溶解性有机碳表征效果更好。     

A survey of northern Victorian dairy farmers to investigate dairy calf management: colostrum feeding and management

Objectives

To describe colostrum management practices carried out in northern Victorian dairy herds and to identify weaknesses in these areas that may affect calf health and welfare by comparing the results with the current industry recommendations

Methods

A questionnaire to obtain information about colostrum management and calf‐rearing practices was sent to commercial dairy farming clients of Rochester Veterinary Practice between June and September 2013. The questionnaire consisted of a general herd overview and colostrum harvesting practices.

Results

The response rate was 39% (58/150). Many dairy producers were not meeting the current industry recommendations in the following areas: (1) time of removal calf from the dam, (2) relying on calf suckling colostrum from the dam to achieve adequate passive transfer, (3) failing to supplement calves with colostrum, (4) feeding inadequate volumes of colostrum, (5) delayed colostrum harvesting, (6) pooling of colostrum, (7) failing to objectively assess colostrum quality or relying on visual assessment and (8) storing colostrum for a prolonged periods of time at ambient temperatures.

Conclusion

The results from this survey highlight the need for greater awareness of industry standards for colostrum management and feeding hygiene.

     

Effect of benazepril and pimobendan on serum angiotensin‐converting enzyme activity in dogs

To support their combined use, the objective of the study was to evaluate the effects of benazepril and pimobendan on serum angiotensin‐converting enzyme (ACE) activity in dogs. A total of 48 healthy beagle dogs were randomized into four groups (n = 12 per group) in a parallel‐group design study: A (control, placebo twice daily (BID)); B (0.5–1.0 mg/kg benazepril once daily (SID) in the morning, placebo in the evening); C (0.25–0.5 mg/kg benazepril BID); D (0.25–0.5 mg/kg benazepril and 0.125–0.25 mg/kg pimobendan, both BID). The test items were administered orally for 15 days. Serum ACE activity was measured on days 1 and 15. Groups B, C and D had significantly lower average serum ACE activity compared to baseline and to the control group, on both days 1 and 15. There were no significant differences in average ACE activity between groups B, C and D. Noninferiority of group C to B was demonstrated. In conclusion, 0.25–0.5 mg/kg benazepril administered BID produced noninferior inhibition of serum ACE activity compared to 0.5–1.0 mg/kg benazepril dosed SID. Pimobendan had no significant effect on benazepril's action on serum ACE activity. The results support the use of benazepril BID in dogs and in combination with pimobendan.